LAVEROCK THERAPEUTICS LIMITED

Company number 13508159 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

-£2,088,522

Balance sheet as at 2022-12-31

View full accounts →

What it does

The principal activity of the company is Research and experimental development on biotechnology

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2021-07-13
Employees
6 (2022 accounts)
Registered office
C/O Xeinadin First Floor Secure House, Lulworth Close, Chandler's Ford, United Kingdom, SO53 3TL
Postcode
SO53 3TL
Capital
92 GBP
Accounts category
Small

Accounts

Last made up to
2025-12-31
Next due by
2027-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2026-07-12
Next due by
2027-07-26
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 4 current · 9 resigned

Appointed 2024-07-19
Appointed 2023-09-27
Appointed 2021-12-22
Appointed 2021-07-13

View all officers and resignations →

Data protection registration

Registered with the ICO as a data protection fee payer — ZB564259 (Tier 1), registered since 2023.

Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.

Previous company names

NameDate changed
SKYLARK THERAPEUTICS LIMITED2022-08-22

At this address

Among the biggest employers

of 17 similar companies in SO, with 6 staff.

Competitors Southampton

This company ranks 28 among research and experimental development on biotechnology in Southampton.

Full league table →